☆ 4.5 Review

COVID-19 in gastroenterology: Where are we now? Current evidence on the impact of COVID-19 in gastroenterology

UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2021)

Related references

Note: Only part of the references are listed.
Article Gastroenterology & Hepatology

Comparative Risk of Serious Infections With Tumor Necrosis Factor α Antagonists vs Vedolizumab in Patients With Inflammatory Bowel Diseases

Siddharth Singh et al.

Summary: A retrospective cohort study found that vedolizumab was associated with a lower risk of serious infections compared to TNFa antagonists in patients with ulcerative colitis, but no significant differences were observed in patients with Crohn's disease.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

Add to Collection
Article Gastroenterology & Hepatology

Impact of COVID-19 on Individuals With Irritable Bowel Syndrome and Comorbid Anxiety and/or Depression

Kendra J. Kamp et al.

Summary: The COVID-19 pandemic has influenced the ability of individuals with IBS and comorbid anxiety and/or depression to engage in activities and has also led to increased psychological distress and gastrointestinal symptoms. The most commonly affected aspects include social interactions, access to specific foods, and healthcare.

JOURNAL OF CLINICAL GASTROENTEROLOGY (2022)

Add to Collection
Article Surgery

Association between Acute Pancreatitis and COVID-19: Could Pancreatitis Be the Missing Piece of the Puzzle about Increased Mortality Rates?

Cevher Akarsu et al.

Summary: This study evaluated the incidence and clinical manifestations of acute pancreatitis in COVID-19 patients. The results showed that COVID-19 patients with acute pancreatitis had higher hospitalization and mortality rates, and were associated with age, C-reactive protein, and ferritin levels.

JOURNAL OF INVESTIGATIVE SURGERY (2022)

Add to Collection
Letter Gastroenterology & Hepatology

Increased Amylase and Lipase in Patients With COVID-19 Pneumonia: Don't Blame the Pancreas Just Yet!

Enrique de-Madaria et al.

GASTROENTEROLOGY (2021)

Add to Collection
Review Immunology

A systematic review of asymptomatic infections with COVID-19

Zhiru Gao et al.

Summary: Since the outbreak of COVID-19 at the end of December 2019, it has caused significant harm and challenges to over 200 countries and regions worldwide. Many patients with COVID-19 are asymptomatic or have only mild symptoms, yet they can still spread the virus, making screening for asymptomatic infections difficult and complicating national prevention and control efforts.

JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2021)

Add to Collection
Article Immunology

Direct Evidence of Active SARS-CoV-2 Replication in the Intestine

Qun Qian et al.

Summary: The study investigated the presence of SARS-CoV-2 virions and pathological changes in the rectal tissues of a COVID-19 patient with rectal adenocarcinoma. Results showed evidence of active replication of SARS-CoV-2 in the patient's rectum during the incubation period, potentially explaining fecal-oral transmission of the virus.

CLINICAL INFECTIOUS DISEASES (2021)

Add to Collection
Article Gastroenterology & Hepatology

Impact of the COVID-19 pandemic on UK endoscopic activity and cancer detection: a National Endoscopy Database Analysis

Matthew D. Rutter et al.

Summary: The study found that the COVID-19 pandemic had a significant impact on endoscopic services and endoscopic cancer diagnosis. Endoscopic activity decreased to 12% of pre-COVID levels, leading to a gradual decrease in the number of cancers detected. Urgent efforts are needed to restore endoscopy capacity to prevent a potential cancer healthcare crisis.

GUT (2021)

Add to Collection
Article Gastroenterology & Hepatology

Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients

Jordi Colmenero et al.

Summary: This study revealed that liver transplant patients have a higher risk of contracting COVID-19, but their mortality rate is lower than the general population. Baseline immunosuppression containing mycophenolate was identified as an independent predictor of severe COVID-19, especially at higher doses.

JOURNAL OF HEPATOLOGY (2021)

Add to Collection
Review Gastroenterology & Hepatology

Liver disease and outcomes among COVID-19 hospitalized patients - A systematic review and meta-analysis

Ashish Sharma et al.

Summary: This meta-analysis focused on the occurrence and association of liver injury, comorbid liver disease, and elevated liver enzymes in COVID-19 confirmed hospitalizations. The findings suggest that acute liver injury and elevated liver enzymes were significantly associated with COVID-19 severity, while comorbid liver disease did not have a significant impact on outcomes.

ANNALS OF HEPATOLOGY (2021)

Add to Collection
Article Gastroenterology & Hepatology

Impact of the COVID-19 pandemic on gastrointestinal endoscopy in the Netherlands: analysis of a prospective endoscopy database

Marten A. Lantinga et al.

Summary: The COVID-19 lockdown led to a significant reduction in the number of endoscopies performed in Dutch hospitals, with a higher likelihood of detecting cancer during endoscopy. After the lockdown was lifted, endoscopy volumes quickly returned to normal, except for colorectal cancer screening.

ENDOSCOPY (2021)

Add to Collection
Article Gastroenterology & Hepatology

Intestinal Inflammation Modulates the Expression of ACE2 and TMPRSS2 and Potentially Overlaps With the Pathogenesis of SARS-CoV-2-related Disease

Mayte Suarez-Farinas et al.

Summary: The study shows that the COVID-19 virus has the ability to invade the intestines, and medications used by IBD patients do not significantly affect receptor expression in uninflamed intestines. There are shared molecular networks between COVID-19 infection and IBD.

GASTROENTEROLOGY (2021)

Add to Collection
Editorial Material Gastroenterology & Hepatology

Winter Is Coming! Clinical, Immunologic, and Practical Considerations for Vaccinating Patients With Inflammatory Bowel Disease During the Coronavirus Disease-2019 Pandemic

Gil Y. Melmed et al.

GASTROENTEROLOGY (2021)

Add to Collection
Editorial Material Gastroenterology & Hepatology

Reduction in Inflammatory Bowel Disease Healthcare During the Coronavirus Disease 2019 Pandemic: A Nationwide Retrospective Cohort Study

Maarten te Groen et al.

GASTROENTEROLOGY (2021)

Add to Collection
Article Gastroenterology & Hepatology

Effect of IBD medications on COVID-19 outcomes: results from an international registry

Ryan C. Ungaro et al.

Summary: Combination therapy and thiopurines may be associated with an increased risk of severe COVID-19, while no significant differences were observed when comparing classes of biologicals. These findings warrant confirmation in large population-based cohorts.

GUT (2021)

Add to Collection
Article Gastroenterology & Hepatology

Immunosuppressive Therapy and Risk of COVID-19 Infection in Patients With Inflammatory Bowel Diseases

Kristin E. Burke et al.

Summary: In a multi-institutional cohort of patients with IBD, the use of systemic immunosuppression was not associated with an increased risk of COVID-19, while obesity was identified as a risk factor for COVID-19.

INFLAMMATORY BOWEL DISEASES (2021)

Add to Collection
Article Gastroenterology & Hepatology

Prevalence and Outcomes of COVID-19 Among Patients With Inflammatory Bowel Disease-A Danish Prospective Population-based Cohort Study

Mohamed Attauabi et al.

Summary: Patients with immune-mediated inflammatory diseases, including IBD, were less susceptible to COVID-19 compared to patients without such diseases, and use of immunosuppressive therapies or disease activity of IBD did not affect the disease course of COVID-19.

JOURNAL OF CROHNS & COLITIS (2021)

Add to Collection
Article Gastroenterology & Hepatology

Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study

Thomas Marjot et al.

Summary: This international registry study demonstrates that patients with cirrhosis are at increased risk of death from COVID-19. Mortality from COVID-19 was particularly high among patients with more advanced cirrhosis and those with alcohol-related liver disease.

JOURNAL OF HEPATOLOGY (2021)

Add to Collection
Article Gastroenterology & Hepatology

Impact of the COVID-19 outbreak and the serum prevalence of SARS-CoV-2 antibodies in patients with inflammatory bowel disease treated with biologic drugs

Fabrizio Bossa et al.

Summary: The study found that treatment with biologic drugs does not increase the risk of SARS-CoV-2 infection in patients with inflammatory bowel disease. The majority of patients did not get infected with the virus, and only a small number experienced mild symptoms, with very few requiring hospitalization.

DIGESTIVE AND LIVER DISEASE (2021)

Add to Collection
Editorial Material Gastroenterology & Hepatology

COVID-19 and Inflammatory Bowel Disease: Lessons Learned, Practical Recommendations, and Unanswered Questions

Ryan C. Ungaro et al.

GASTROENTEROLOGY (2021)

Add to Collection
Letter Gastroenterology & Hepatology

Cytokine Storm in IBD: Balancing the Risks of IBD Medical Therapy

Iago Rodriguez-Lago et al.

GASTROENTEROLOGY (2021)

Add to Collection
Article Gastroenterology & Hepatology

Protective Role of Tacrolimus, Deleterious Role of Age and Comorbidities in Liver Transplant Recipients With Covid-19: Results From the ELITA/ELTR Multi-center European Study

Luca S. Belli et al.

Summary: Despite concerns, data from adult liver transplant recipients with COVID-19 infection in Europe shows that age over 70, diabetes, and chronic kidney disease are associated with increased risk of death, while the use of tacrolimus may improve survival rates in these patients.

GASTROENTEROLOGY (2021)

Add to Collection
Article Gastroenterology & Hepatology

Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19

Yun Kit Yeoh et al.

Summary: This study found that the gut microbiome composition was significantly altered in patients with COVID-19 compared to non-COVID-19 individuals, regardless of medication received. Certain gut commensals known for their immunomodulatory potential were underrepresented in patients and remained low even after disease resolution. Additionally, the altered gut microbiome composition correlated with disease severity and elevated levels of inflammatory cytokines and blood markers.

GUT (2021)

Add to Collection
Article Gastroenterology & Hepatology

SARS-CoV-2 vaccination for patients with inflammatory bowel diseases: recommendations from an international consensus meeting

Corey A. Siegel et al.

GUT (2021)

Add to Collection
Article Gastroenterology & Hepatology

Characteristics and Outcomes of IBD Patients with COVID-19 on Tofacitinib Therapy in the SECURE-IBD Registry

Manasi Agrawal et al.

INFLAMMATORY BOWEL DISEASES (2021)

Add to Collection
Article Gastroenterology & Hepatology

Physician Practice Patterns in Holding Inflammatory Bowel Disease Medications due to COVID-19, in the SECURE-IBD Registry

Manasi Agrawal et al.

Summary: More than one third of IBD patients stopped medication due to COVID-19, with those diagnosed with ulcerative colitis or IBD-unspecified less likely to stop compared to Crohn's disease patients. Specific medications such as 5-aminosalicylic acid were more likely to be continued, while anti-tumour necrosis factor therapy and immunomodulator therapy were more likely to be stopped. Other demographic and clinical characteristics did not impact prescription patterns.

JOURNAL OF CROHNS & COLITIS (2021)

Add to Collection
Article Infectious Diseases

Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study

Oscar Moreno-Perez et al.

Summary: This study found that Post-acute COVID-19 syndrome was detected in about half of COVID-19 survivors, with mostly mild symptoms. Radiological and spirometric changes were observed in less than 25% of patients, and no baseline clinical features behaved as independent predictors of Post-acute COVID-19 syndrome development.

JOURNAL OF INFECTION (2021)

Add to Collection
Article Medicine, General & Internal

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey et al.

Summary: The ChAdOx1 nCoV-19 vaccine has been shown to have an acceptable safety profile and effectiveness against symptomatic COVID-19, with higher efficacy observed in the group that received a low dose followed by a standard dose.

LANCET (2021)

Add to Collection
Editorial Material Gastroenterology & Hepatology

COVID-19 and acute pancreatitis: examining the causality

Enrique de-Madaria et al.

Summary: There is reported association between acute pancreatitis and COVID-19 as SARS-CoV-2 receptors are expressed in the pancreas. Despite biases, further investigation is necessary to explore this hypothesis.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)

Add to Collection
Article Medicine, General & Internal

Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine

J. Sadoff et al.

Summary: The study conducted a multicenter, placebo-controlled, phase 1-2a trial, with participants randomly assigned to receive the Ad26.COV2.S vaccine. The results showed that the safety and immunogenicity profiles of the vaccine support further development.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection
Article Gastroenterology & Hepatology

High lipasemia is frequent in Covid-19 associated acute respiratory distress syndrome

Sebastian Rasch et al.

Summary: A high level of serum lipase activity is a common finding in severe Covid-19 associated ARDS, without typical signs of acute pancreatitis. The elevated lipase activity may be explained by impaired microcirculation in severely ill patients.

PANCREATOLOGY (2021)

Add to Collection
Article Respiratory System

Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort

David T. Arnold et al.

Summary: The study found that most COVID-19 patients still experienced persistent symptoms and limitations in physical ability during the recovery period, but clinically significant abnormalities in chest radiograph, exercise tests, blood tests, and spirometry were less frequent, especially in patients who did not require supplementary oxygen during their acute infection.

THORAX (2021)

Add to Collection
Review Gastroenterology & Hepatology

Risk and outcomes of coronavirus disease in patients with inflammatory bowel disease: A systematic review and meta-analysis

Anupam Kumar Singh et al.

Summary: The risk of SARS-CoV-2 infection in patients with inflammatory bowel disease is comparable to the general population, with worse outcomes in ulcerative colitis, patients on steroids or 5-aminosalicylates, but better outcomes with biological agents.

UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2021)

Add to Collection
Letter Oncology

Cancer Screening Tests and Cancer Diagnoses During the COVID-19 Pandemic

Ziad Bakouny et al.

Summary: This cohort study examines the number of patients receiving cancer screening tests and subsequent cancer diagnoses in one healthcare system in the northeastern United States during the COVID-19 pandemic.

JAMA ONCOLOGY (2021)

Add to Collection
Review Gastroenterology & Hepatology

SARS-CoV-2 vaccination for patients with inflammatory bowel disease: a British Society of Gastroenterology Inflammatory Bowel Disease section and IBD Clinical Research Group position statement

James L. Alexander et al.

Summary: SARS-CoV-2 vaccination in patients with IBD is supported due to anticipated low risks, despite some concerns that protective immune responses may be diminished in certain patients. Further research is needed to address vaccine hesitancy, the impact of immunosuppression, and the search for predictive biomarkers of vaccine success.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2021)

Add to Collection
Letter Immunology

Do COVID-19 RNA-based vaccines put at risk of immune-mediated diseases? In reply to potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases

Rossella Talotta

CLINICAL IMMUNOLOGY (2021)

Add to Collection
Review Gastroenterology & Hepatology

Successful Distancing: Telemedicine in Gastroenterology and Hepatology During the COVID-19 Pandemic

Abhilash Perisetti et al.

Summary: Telemedicine has seen a significant increase in utilization during the COVID-19 pandemic, particularly in gastroenterology, due to relaxed regulations and the need for remote care. While it offers advantages such as timely care and reduced exposure, challenges remain in terms of lack of direct patient contact and lower reimbursements.

DIGESTIVE DISEASES AND SCIENCES (2021)

Add to Collection
Article Gastroenterology & Hepatology

STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD

Dan Turner et al.

Summary: STRIDE-II presents treatment targets for both adult and pediatric IBD, including long-term and short-term goals. These targets cover aspects such as clinical response, endoscopic healing, quality of life, and growth, providing guidance for improving patient outcomes.

GASTROENTEROLOGY (2021)

Add to Collection
Article Gastroenterology & Hepatology

SARS-CoV-2 infection in acute pancreatitis increases disease severity and 30-day mortality: COVID PAN collaborative study

Sanjay Pandanaboyana et al.

Summary: Patients with acute pancreatitis and coexistent SARS-CoV-2 infection are at higher risk of developing severe pancreatitis, acute respiratory distress syndrome (ARDS), prolonged hospital stays, and increased 30-day mortality.

GUT (2021)

Add to Collection
Article Gastroenterology & Hepatology

Outcome of COVID-19 in Patients With Autoimmune Hepatitis: An International Multicenter Study

Cumali Efe et al.

Summary: This international, multicenter study showed that patients with AIH did not have worse outcomes with COVID-19 compared to other causes of chronic liver diseases. Cirrhosis was identified as the strongest predictor for severe COVID-19 in AIH patients. Continuing immunosuppression during COVID-19 did not increase the risk for severe COVID-19, but rather lowered the risk for new-onset liver injury during COVID-19.

HEPATOLOGY (2021)

Add to Collection
Article Gastroenterology & Hepatology

Impact of the coronavirus disease 2019 pandemic on irritable bowel syndrome

Sabrina Xin Zi Quek et al.

Summary: The study revealed that respondents with self-reported IBS had poorer emotional, social, and psychological well-being compared to non-IBS respondents, and were less compliant to social distancing measures. Those willing to adhere to social distancing indefinitely had a higher proportion of no change in IBS symptoms.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2021)

Add to Collection
Article Gastroenterology & Hepatology

EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients

Markus Cornberg et al.

Summary: According to a recent estimate by the World Health Organization, the SARS-CoV-2 pandemic has affected nearly 100 million people globally, with patients with chronic liver diseases (CLD) at higher risk of infections. Vaccination against various pathogens, including SARS-CoV-2, is important for these patients, although impaired immune responses may affect the efficacy of immunization. The safety, immunogenicity, and efficacy of SARS-CoV-2 vaccines in patients with CLD, cirrhosis, hepatobiliary cancer, and liver transplant recipients still require further study.

JOURNAL OF HEPATOLOGY (2021)

Add to Collection
Article Medicine, General & Internal

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

Merryn Voysey et al.

Summary: The AZD1222 vaccine has been approved for emergency use in the UK with an interval of 4-12 weeks between doses. Analysis shows that the vaccine is efficacious with two doses and provides immunoprotection after the first dose before the second dose is administered.

LANCET (2021)

Add to Collection
Article Medicine, General & Internal

Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia

Denis Y. Logunov et al.

Summary: The Gam-COVID-Vac vaccine showed 91.6% efficacy against COVID-19 in the phase 3 trial, with good safety and tolerability in a large cohort of participants.

LANCET (2021)

Add to Collection
Article Gastroenterology & Hepatology

Potential intestinal infection and faecal-oral transmission of SARS-CoV-2

Meng Guo et al.

Summary: SARS-CoV-2, in addition to respiratory transmission, can also cause gastrointestinal symptoms, with detectable RNA in fecal samples of some patients. Infection alters intestinal microbiota, correlated with inflammatory factors. Multiple studies provide evidence of intestinal infection and potential for fecal-oral transmission.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)

Add to Collection
Review Gastroenterology & Hepatology

COVID-19 and liver disease: mechanistic and clinical perspectives

Thomas Marjot et al.

Summary: This article provides insights into the mechanistic and clinical aspects of COVID-19 in the context of liver disease, discussing viral hepatotropism, differential expression of viral receptors on liver cell types, and liver histology features in COVID-19 patients. It also highlights the impact of COVID-19 on patients with pre-existing chronic liver disease and the potential strategies for managing these patients, including vaccination.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)

Add to Collection
Article Medicine, General & Internal

BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting

Noa Dagan et al.

Summary: A study conducted in Israel on nearly 600,000 individuals showed that the BNT162b2 mRNA vaccine was effective in reducing the risk of infection, hospitalization, and severe Covid-19. The effectiveness in preventing death was 72% during the period from day 14 through day 20 after the first dose, and hospitalization was reduced by 87% for the period 7 or more days after the second dose, similar to results from a randomized trial.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection
News Item Medicine, General & Internal

Covid-19: Pfizer BioNTech vaccine reduced cases by 94% in Israel, shows peer reviewed study

Jacqui Wise

BMJ-BRITISH MEDICAL JOURNAL (2021)

Add to Collection
Article Cell Biology

The effect of spike mutations on SARS-CoV-2 neutralization

Chloe Rees-Spear et al.

Summary: The study found that emerging variants of the coronavirus may lead to reduced neutralization by antibodies induced by vaccines or previous infection, but some samples still retain effectiveness. This highlights the importance of real-time monitoring of emerging mutations and their impact on vaccine efficacy.

CELL REPORTS (2021)

Add to Collection
Article Gastroenterology & Hepatology

Inflammatory bowel disease and risk of severe COVID-19: A nationwide population-based cohort study in Sweden

Jonas F. Ludvigsson et al.

Summary: While individuals with IBD were more likely to be admitted to hospital for COVID-19 than the general population, the risk of severe COVID-19 was not higher.

UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2021)

Add to Collection
Article Gastroenterology & Hepatology

Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab

Nicholas A. Kennedy et al.

Summary: The study found that patients with inflammatory bowel disease treated with infliximab had attenuated serological responses to SARS-CoV-2 infection. Additionally, the serological response to SARS-CoV-2 infection in the infliximab-treated group was further blunted by concomitant use of immunomodulators.

GUT (2021)

Add to Collection
Review Gastroenterology & Hepatology

SARS-CoV-2 Vaccination in IBD: Past Lessons, Current Evidence, and Future Challenges

Judith Wellens et al.

Summary: Patients with inflammatory bowel diseases (IBD) have been considered high-risk for COVID-19 infection and complications since the start of the pandemic. However, they were excluded from clinical phase III vaccine trials, leading to challenges in assessing the effectiveness of new vaccines. Adapted vaccination strategies may be needed for some IBD patients to optimize immune response. Therefore, further research is needed to develop tailored vaccination plans for IBD patients.

JOURNAL OF CROHNS & COLITIS (2021)

Add to Collection
Review Biochemistry & Molecular Biology

Post-acute COVID-19 syndrome

Ani Nalbandian et al.

Summary: SARS-CoV-2 is responsible for the COVID-19 pandemic, causing global healthcare crises. Recovery from COVID-19 may lead to persistent symptoms and long-term complications, prompting the need for multidisciplinary care and follow-up for survivors.

NATURE MEDICINE (2021)

Add to Collection
Article Medicine, General & Internal

Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination

Nina H. Schultz et al.

Summary: This study reports five cases of venous thrombosis and thrombocytopenia occurring 7 to 10 days after receiving the ChAdOx1 nCoV-19 vaccine, suggesting a rare vaccine-induced immune thrombotic thrombocytopenia. The condition, which can lead to catastrophic outcomes such as cerebral venous sinus thrombosis, may be treated with intravenous immune globulin.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection
Article Medicine, General & Internal

Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination

Andreas Greinacher et al.

Summary: After vaccination with ChAdOx1 nCov-19, rare immune thrombotic thrombocytopenia can occur due to platelet-activating antibodies against PF4, resulting in various thrombotic events. Most patients in this case series were women, with fatal outcomes such as cerebral venous thrombosis and intracranial hemorrhage. Additional studies are needed to further investigate and understand this phenomenon.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection
Letter Medicine, General & Internal

Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination - Response from the Manufacturer

Jerald Sadoff et al.

Summary: The manufacturer responds to recent reports of thrombosis and severe thrombocytopenia in recipients of the Ad26.COV2.S vaccine.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection
Editorial Material Gastroenterology & Hepatology

Implications of COVID-19 for patients with pre-existing digestive diseases: an update Comment

Ren Mao et al.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2021)

Add to Collection
Article Endocrinology & Metabolism

SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas

Janis A. Mueller et al.

Summary: The study shows that SARS-CoV-2 can infect and impact insulin secretion in human pancreatic cells, potentially contributing to metabolic dysregulation observed in COVID-19 patients.

NATURE METABOLISM (2021)

Add to Collection
Article Gastroenterology & Hepatology

Increased incidence of systemic serious viral infections in patients with inflammatory bowel disease associates with active disease and use of thiopurines

Andrew Wisniewski et al.

UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2020)

Add to Collection
Editorial Material Gastroenterology & Hepatology

Evidence for Gastrointestinal Infection of SARS-CoV-2

Fei Xiao et al.

GASTROENTEROLOGY (2020)

Add to Collection
Review Gastroenterology & Hepatology

Review article: prevention, diagnosis and management of COVID-19 in the IBD patient

Aysha H. Al-Ani et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)

Add to Collection
Review Gastroenterology & Hepatology

COVID-19 and the Digestive System

Chunxiang Ma et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2020)

Add to Collection
Article Oncology

Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic

A. Sud et al.

ANNALS OF ONCOLOGY (2020)

Add to Collection
Article Biochemistry & Molecular Biology

Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses

Furong Qi et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)

Add to Collection
Letter Immunology

The emotional impact of COVID-19: From medical staff to common people

Nicola Montemurro

BRAIN BEHAVIOR AND IMMUNITY (2020)

Add to Collection
Letter Gastroenterology & Hepatology

ACE2 Expression in Pancreas May Cause Pancreatic Damage After SARS-CoV-2 Infection

Furong Liu et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)

Add to Collection
Letter Gastroenterology & Hepatology

Endoscopic Findings in Patients Infected With 2019 Novel Coronavirus in Lombardy, Italy

Sara Massironi et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)

Add to Collection
Article Gastroenterology & Hepatology

Impact of the COVID-19 pandemic on Gastroenterology Divisions in Italy: A national survey

M. Maida et al.

DIGESTIVE AND LIVER DISEASE (2020)

Add to Collection
Editorial Material Gastroenterology & Hepatology

Gastrointestinal and Hepatic Manifestations of 2019 Novel Coronavirus Disease in a Large Cohort of Infected Patients From New York: Clinical Implications

Kaveh Hajifathalian et al.

GASTROENTEROLOGY (2020)

Add to Collection
Editorial Material Gastroenterology & Hepatology

How To Maximize Trainee Education During the Coronavirus Disease-2019 Pandemic: Perspectives From Around the World

Rajesh N. Keswani et al.

GASTROENTEROLOGY (2020)

Add to Collection
Editorial Material Gastroenterology & Hepatology

Characteristics and Prognosis of Patients With Inflammatory Bowel Disease During the SARS-CoV-2 Pandemic in the Basque Country (Spain)

Iago Rodriguez-Lago et al.

GASTROENTEROLOGY (2020)

Add to Collection
Editorial Material Gastroenterology & Hepatology

Age, Inflammation, and Disease Location Are Critical Determinants of Intestinal Expression of SARS-CoV-2 Receptor ACE2 and TMPRSS2 in Inflammatory Bowel Disease

Jan Krzysztof Nowak et al.

GASTROENTEROLOGY (2020)

Add to Collection
Article Gastroenterology & Hepatology

Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry

Erica J. Brenner et al.

GASTROENTEROLOGY (2020)

Add to Collection
Article Gastroenterology & Hepatology

Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization

Tao Zuo et al.

GASTROENTEROLOGY (2020)

Add to Collection
Editorial Material Gastroenterology & Hepatology

Pancreatic Injury Patterns in Patients With Coronavirus Disease 19 Pneumonia

Fan Wang et al.

GASTROENTEROLOGY (2020)

Add to Collection
Article Gastroenterology & Hepatology

Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples From a Hong Kong Cohort: Systematic Review and Meta-analysis

Ka Shing Cheung et al.

GASTROENTEROLOGY (2020)

Add to Collection
Editorial Material Gastroenterology & Hepatology

Innovation in Inflammatory Bowel Disease Care During the COVID-19 Pandemic: Results of a Global Telemedicine Survey by the International Organization for the Study of Inflammatory Bowel Disease

Charlie W. Lees et al.

GASTROENTEROLOGY (2020)

Add to Collection
Article Gastroenterology & Hepatology

AGA Clinical Practice Update on Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: Expert Commentary

David T. Rubin et al.

GASTROENTEROLOGY (2020)

Add to Collection
Article Gastroenterology & Hepatology

Management of Patients with Crohn’s Disease and Ulcerative Colitis During the COVID-19 Pandemic: Results of an International Meeting

David T. Rubin et al.

GASTROENTEROLOGY (2020)

Add to Collection
Editorial Material Gastroenterology & Hepatology

Impact of Anti-Tumor Necrosis Factor and Thiopurine Medications on the Development of COVID-19 in Patients With Inflammatory Bowel Disease: A Nationwide Veterans Administration Cohort Study

Nabeel Khan et al.

GASTROENTEROLOGY (2020)

Add to Collection
Letter Gastroenterology & Hepatology

Gastrointestinal endoscopy during the COVID-19 pandemic: an updated review of guidelines and statements from international and national societies

Elio C. Castro Filho et al.

GASTROINTESTINAL ENDOSCOPY (2020)

Add to Collection
Article Gastroenterology & Hepatology

Considerations in performing endoscopy during the COVID-19 pandemic

Roy Soetikno et al.

GASTROINTESTINAL ENDOSCOPY (2020)

Add to Collection
Article Gastroenterology & Hepatology

COVID-19 pandemic through the lens of a gastroenterology fellow: looking for the silver lining

Raj Shah et al.

GASTROINTESTINAL ENDOSCOPY (2020)

Add to Collection
Letter Gastroenterology & Hepatology

Faecal calprotectin indicates intestinal inflammation in COVID-19

Maria Effenberger et al.

GUT (2020)

Add to Collection
Article Gastroenterology & Hepatology

Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study

Cristina Bezzio et al.

GUT (2020)

Add to Collection
Article Gastroenterology & Hepatology

Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms

Xi Jin et al.

GUT (2020)

Add to Collection
Article Multidisciplinary Sciences

SARS-CoV-2 productively infects human gut enterocytes

Mart M. Lamers et al.

SCIENCE (2020)

Add to Collection
Review Gastroenterology & Hepatology

Gastrointestinal and hepatic manifestations of COVID-19: A comprehensive review

Ming Han Cha et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2020)

Add to Collection
Article Medicine, General & Internal

Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study

Shufa Zheng et al.

BMJ-BRITISH MEDICAL JOURNAL (2020)

Add to Collection
Letter Gastroenterology & Hepatology

COVID-19 and viral hepatitis elimination programs: Are we stepping backward?

Hamidreza Karimi-Sari et al.

LIVER INTERNATIONAL (2020)

Add to Collection
Editorial Material Gastroenterology & Hepatology

COVID-19 and liver disease

Jian Sun et al.

LIVER INTERNATIONAL (2020)

Add to Collection
Letter Gastroenterology & Hepatology

Tips from the battlefront: Psychological support of patients with a chronic illness during the COVID-19 lockdown in four steps

Carolina Ciacci et al.

UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2020)

Add to Collection
Review Gastroenterology & Hepatology

The daily impact of COVID-19 in gastroenterology

Fernando Magro et al.

UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2020)

Add to Collection
Article Gastroenterology & Hepatology

Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre

Franco Scaldaferri et al.

UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2020)

Add to Collection
Review Gastroenterology & Hepatology

Liver injury in COVID-19: The current evidence

Saleh A. Alqahtani et al.

UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2020)

Add to Collection
Article Engineering, Environmental

Presence of SARS-Coronavirus-2 RNA in Sewage and Correlation with Reported COVID-19 Prevalence in the Early Stage of the Epidemic in The Netherlands

Gertjan Medema et al.

ENVIRONMENTAL SCIENCE & TECHNOLOGY LETTERS (2020)

Add to Collection
Article Multidisciplinary Sciences

Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor

Jun Lan et al.

NATURE (2020)

Add to Collection
Article Multidisciplinary Sciences

Virological assessment of hospitalized patients with COVID-2019

Roman Woelfel et al.

NATURE (2020)

Add to Collection
Article Biochemistry & Molecular Biology

Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding

Yi Xu et al.

NATURE MEDICINE (2020)

Add to Collection
Editorial Material Gastroenterology & Hepatology

Management of IBD during the COVID-19 outbreak: resetting clinical priorities

Silvio Danese et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)

Add to Collection
Letter Gastroenterology & Hepatology

Prolonged presence of SARS-CoV-2 viral RNA in faecal samples

Yongjian Wu et al.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)

Add to Collection
Article Medicine, Research & Experimental

Clinical Characteristics of Children with Coronavirus Disease 2019 in Hubei, China

Fang Zheng et al.

CURRENT MEDICAL SCIENCE (2020)

Add to Collection
Editorial Material Gastroenterology & Hepatology

Current evidence on pancreatic involvement in SARS-CoV-2 infection

Wajana Thaweerat

PANCREATOLOGY (2020)

Add to Collection
Article Gastroenterology & Hepatology

Coronavirus Disease-19 (COVID-19) associated with severe acute pancreatitis: Case report on three family members

Amer Hadi et al.

PANCREATOLOGY (2020)

Add to Collection
Article Gastroenterology & Hepatology

Lipase Elevation in Patients With COVID-19

Julia McNabb-Baltar et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2020)

Add to Collection
Article Gastroenterology & Hepatology

Outrunning Burnout in a GI Fellowship Program During the COVID-19 Pandemic

Andrew Ming-Liang Ong

DIGESTIVE DISEASES AND SCIENCES (2020)

Add to Collection
Editorial Material Gastroenterology & Hepatology

The New Virtual Reality: Advanced Endoscopy Education in the COVID-19 Era

Uzma D. Siddiqui et al.

DIGESTIVE DISEASES AND SCIENCES (2020)

Add to Collection
Article Gastroenterology & Hepatology

ESGE and ESGENA Position Statement on gastrointestinal endoscopy and COVID-19: An update on guidance during the post-lockdown phase and selected results from a membership survey

Ian M. Gralnek et al.

ENDOSCOPY (2020)

Add to Collection
Editorial Material Gastroenterology & Hepatology

The Impact of COVID-19 on Gastrointestinal Endoscopy Training in the United Kingdom

Keith Siau et al.

GASTROENTEROLOGY (2020)

Add to Collection
Editorial Material Gastroenterology & Hepatology

Positive Early Patient and Clinician Experience with Telemedicine in an Academic Gastroenterology Practice During the COVID-19 Pandemic

Marina Serper et al.

GASTROENTEROLOGY (2020)

Add to Collection
Article Gastroenterology & Hepatology

Impact of COVID-19 on endoscopy trainees: an international survey

Katarzyna M. Pawlak et al.

GASTROINTESTINAL ENDOSCOPY (2020)

Add to Collection
Review Gastroenterology & Hepatology

Coronavirus disease (COVID-19) and the liver: a comprehensive systematic review and meta-analysis

Praveen Kumar-M et al.

HEPATOLOGY INTERNATIONAL (2020)

Add to Collection
Article Gastroenterology & Hepatology

Management of COVID-19 Pandemic in Spanish Inflammatory Bowel Disease Units: Results From a National Survey

Eduardo Martin Arranz et al.

INFLAMMATORY BOWEL DISEASES (2020)

Add to Collection
Letter Gastroenterology & Hepatology

Gastrointestinal endoscopy and the COVID-19 pandemic: Urgent issues in endoscopic retrograde cholangio-pancreatography and endoscopic training

Ivo Boskoski et al.

UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2020)

Add to Collection
Article Gastroenterology & Hepatology

Endoscopy works during the pandemic of coronavirus COVID-19: recommendations by the Chinese Society of Digestive Endoscopy

Ningli Chai et al.

UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2020)

Add to Collection
Article Gastroenterology & Hepatology

Patterns of liver injury in COVID-19-a German case series

Joern M. Schattenberg et al.

UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2020)

Add to Collection
Article Gastroenterology & Hepatology

Marked Elevation of Lipase in COVID-19 Disease: A Cohort Study

Usman Barlass et al.

Clinical and Translational Gastroenterology (2020)

Add to Collection
Letter Gastroenterology & Hepatology

Effect of COVID-19 lockdown on alcohol consumption in patients with pre-existing alcohol use disorder

Jin Un Kim et al.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)

Add to Collection
Article Virology

Gastrointestinal, hepatobiliary, and pancreatic manifestations of COVID-19

Kishan P. Patel et al.

JOURNAL OF CLINICAL VIROLOGY (2020)

Add to Collection
Article Gastroenterology & Hepatology

Inflammatory Bowel Disease Management During the COVID-19 Outbreak: The Ten Do's and Don'ts from the ECCO-COVID Taskforce

F. Magro et al.

JOURNAL OF CROHNS & COLITIS (2020)

Add to Collection
Letter Medicine, General & Internal

Changes in the Number of US Patients With Newly Identified Cancer Before and During the Coronavirus Disease 2019 (COVID-19) Pandemic

Harvey W. Kaufman et al.

JAMA NETWORK OPEN (2020)

Add to Collection
Article Oncology

The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study

Camille Maringe et al.

LANCET ONCOLOGY (2020)

Add to Collection
Article Multidisciplinary Sciences

Longitudinal analyses reveal immunological misfiring in severe COVID-19

Carolina Lucas et al.

NATURE (2020)

Add to Collection
Review Biochemistry & Molecular Biology

Extrapulmonary manifestations of COVID-19

Aakriti Gupta et al.

NATURE MEDICINE (2020)

Add to Collection
Editorial Material Gastroenterology & Hepatology

COVID-19 and liver transplantation

Tommaso Di Maira et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)

Add to Collection
Editorial Material Multidisciplinary Sciences

COVID-19 and cancer

Norman E. Sharpless

SCIENCE (2020)

Add to Collection
Article Environmental Sciences

COVID-19: Disease, management, treatment, and social impact

Imran Ali et al.

SCIENCE OF THE TOTAL ENVIRONMENT (2020)

Add to Collection
Article Gastroenterology & Hepatology

Prevalence, Risk Factors, and Outcomes of Hospitalized Patients With Coronavirus Disease 2019 Presenting as Acute Pancreatitis

Suman Inamdar et al.

GASTROENTEROLOGY (2020)

Add to Collection
Review Gastroenterology & Hepatology

COVID-19 pandemic: Its impact on liver disease and liver transplantation

Tevfik Tolga Sahin et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2020)

Add to Collection
Review Surgery

The socio-economic implications of the coronavirus pandemic (COVID-19): A review

Maria Nicola et al.

INTERNATIONAL JOURNAL OF SURGERY (2020)

Add to Collection
Editorial Material Gastroenterology & Hepatology

Telemedicine in gastroenterology in the wake of COVID-19

Lauren A. George et al.

EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2020)

Add to Collection
Article Medicine, General & Internal

Current and future implications of COVID-19 on gastroenterology training and clinical practice

Hemant Goyal et al.

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2020)

Add to Collection
Editorial Material Oncology

Propelling a New Era of Patient Education into Practice-Cancer Care Post-COVID-19

Meredith Giuliani et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2020)

Add to Collection
Letter Medicine, General & Internal

Gastrointestinal Complications in Critically Ill Patients With and Without COVID-19

Mohamad El Moheb et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Add to Collection
Article Gastroenterology & Hepatology

International Organization for the Study of Inflammatory Bowel Disease: Global Strategies for Telemedicine and Inflammatory Bowel Diseases

Sara Lewin et al.

JOURNAL OF CROHNS & COLITIS (2020)

Add to Collection
Article Medicine, General & Internal

Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia

Denis Y. Logunov et al.

LANCET (2020)

Add to Collection
Article Medicine, General & Internal

Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine

Cheryl Keech et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection
Editorial Material Multidisciplinary Sciences

Reimagining scientific conferences during the pandemic and beyond

Thale Jarvis et al.

SCIENCE ADVANCES (2020)

Add to Collection
Article Medicine, General & Internal

Coronavirus disease-19 (COVID-19) associated with acute necrotising pancreatitis (ANP)

Naren K. Kumaran et al.

BMJ CASE REPORTS (2020)

Add to Collection
Review Gastroenterology & Hepatology

Insufficient etiological workup of COVID-19-associated acute pancreatitis: A systematic review

Mark Felix Juhasz et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2020)

Add to Collection
Article Endocrinology & Metabolism

SARS-CoV-2 Receptor Angiotensin I-Converting Enzyme Type 2 (ACE2) Is Expressed in Human Pancreatic β-Cells and in the Human Pancreas Microvasculature

Daniela Fignani et al.

FRONTIERS IN ENDOCRINOLOGY (2020)

Add to Collection
Article Biology

Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants

Yiska Weisblum et al.

ELIFE (2020)

Add to Collection
Article Gastroenterology & Hepatology

Aspects of inflammatory bowel disease during the COVID-19 pandemic and general considerations

J. L. de Leon-Rendon et al.

REVISTA DE GASTROENTEROLOGIA DE MEXICO (2020)

Add to Collection
Article Gastroenterology & Hepatology

Relevant Infections in Inflammatory Bowel Disease, and Their Relationship With Immunosuppressive Therapy and Their Effects on Disease Mortality

Yamile Zabana et al.

JOURNAL OF CROHNS & COLITIS (2019)

Add to Collection
Review Microbiology

Origin and evolution of pathogenic coronaviruses

Jie Cui et al.

NATURE REVIEWS MICROBIOLOGY (2019)

Add to Collection
Article Pharmacology & Pharmacy

Risk of Hepatitis B Reactivation in Patients with Psoriasis on Ustekinumab

Sze-Wen Ting et al.

CLINICAL DRUG INVESTIGATION (2018)

Add to Collection
Article Gastroenterology & Hepatology

Risk of Serious and Opportunistic Infections Associated With Treatment of Inflammatory Bowel Diseases

Julien Kirchgesner et al.

GASTROENTEROLOGY (2018)

Add to Collection
Review Gastroenterology & Hepatology

Telemedicine in the treatment of patients with inflammatory bowel disease

Mariam Aguas et al.

GASTROENTEROLOGIA Y HEPATOLOGIA (2017)

Add to Collection
Article Gastroenterology & Hepatology

Many Inflammatory Bowel Disease Patients Are Not Immune to Measles or Pertussis

Noa Krugliak Cleveland et al.

DIGESTIVE DISEASES AND SCIENCES (2016)

Add to Collection
Article Gastroenterology & Hepatology

Kinetics of Anti-Hepatitis B Surface Antigen Titers After Hepatitis B Vaccination in Patients With Inflammatory Bowel Disease

Javier P. Gisbert et al.

INFLAMMATORY BOWEL DISEASES (2013)

Add to Collection
Article Endocrinology & Metabolism

Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes

Jin-Kui Yang et al.

ACTA DIABETOLOGICA (2010)

Add to Collection
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.